Tender Intelligence
Top suppliers in nhs england
Supplier concentration analysis across recent public contract awards, highlighting repeat winner behaviour and buyer coverage.
Market context
This top-supplier intelligence page focuses on supplier concentration and buyer coverage within NHS England contracts. It helps teams see whether spend is distributed across multiple suppliers or concentrated among repeat winners. That distinction is commercially important: concentrated markets require stronger differentiation and deeper account mapping, while distributed markets often create more accessible routes for challenger bids. The table and summaries below combine title, buyer, supplier disclosure and value indicators so you can assess competitiveness with evidence, not assumptions. Current sample size: 25 records.
Contract table
| Contract title | Buyer | Supplier | Value | Date |
|---|---|---|---|---|
| NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets | NHS England | Not disclosed in public notice | Not disclosed | 29 Jul 2026 |
| Urgent Award - haematological screening | NHS England | Not disclosed in public notice | Not disclosed | 29 Jul 2026 |
| NHS National Framework for Aripiprazole prolonged release injection | NHS England | Not disclosed in public notice | Not disclosed | 29 Jul 2026 |
| Incentive Voucher Provider | NHS England | Not disclosed in public notice | £60,000 | 29 Jul 2026 |
| IAM Platforms | NHS England | Not disclosed in public notice | £42,550,000 | 28 Jul 2026 |
| CRM for NHSE participant/candidate data 26-27 | NHS England | Not disclosed in public notice | £56,640 | 28 Jul 2026 |
| Exam Support Packages for EoE GP Registrars | NHS England | Not disclosed in public notice | Not disclosed | 24 Jul 2026 |
| Northamptonshire Non-Custodial Services (Liaison and Diversion, MHTR and Reconnect) | NHS England | Not disclosed in public notice | Not disclosed | 24 Jul 2026 |
| MSRA / SJT Discovery | NHS England | Not disclosed in public notice | Not disclosed | 23 Jul 2026 |
| NHS UK Service Engine Optimisation | NHS England | Not disclosed in public notice | £194,400 | 23 Jul 2026 |
| Refer a Patient - Adult ECMO 2026/27 | NHS England | Not disclosed in public notice | Not disclosed | 23 Jul 2026 |
| Smartcard Printer Re-Procurement | NHS England | Not disclosed in public notice | £653,045 | 23 Jul 2026 |
| Wayfinder and First Contact Digital Clinical Support 2026-27 | NHS England | Not disclosed in public notice | £748,000 | 23 Jul 2026 |
| Executive Leadership and Development Support | NHS England | Not disclosed in public notice | Not disclosed | 23 Jul 2026 |
| Support Services for PPM application | NHS England | Not disclosed in public notice | £860,000 | 22 Jul 2026 |
| Imaging National Lecture Series | NHS England | Not disclosed in public notice | Not disclosed | 22 Jul 2026 |
| Digital Maturity Assessment | NHS England | Not disclosed in public notice | Not disclosed | 21 Jul 2026 |
| Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service | NHS England | Not disclosed in public notice | Not disclosed | 21 Jul 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 | NHS England | Not disclosed in public notice | Not disclosed | 21 Jul 2026 |
| NexGen Knee Implant Independent Investigation (IPSI) | NHS England | Not disclosed in public notice | £81,635 | 20 Jul 2026 |
| Location and Maps Service for 111.nhs.uk & NHSSF | NHS England | Not disclosed in public notice | £424,077 | 20 Jul 2026 |
| Integrated Screening Outcomes Surveillance Service (ISOSS) | NHS England | Not disclosed in public notice | Not disclosed | 17 Jul 2026 |
| NHSE987 - Eye Testing in Special Education Settings in North West | NHS England - North West | Not disclosed in public notice | Not disclosed | 17 Jul 2026 |
| NBIA - Breast Clinician Credential | NHS England | Not disclosed in public notice | Not disclosed | 16 Jul 2026 |
| UK Rehabilitation Outcomes Collective (UKROC) | NHS England | Not disclosed in public notice | Not disclosed | 16 Jul 2026 |
Market signal snapshot
Why this page is distinct
- Scope fingerprint: NHS England contracts.
- Entity mix: 2 buyers, 1 suppliers, 2 categories.
- Notice date span: 16 Jul 2026 to 29 Jul 2026.
- Supplier leaderboard reliability for this URL: 0% disclosure.
Data-driven insights
Across 25 supplier-linked records, the combined published value is £45,627,797 with an average contract size of £1,825,112. Supplier concentration in this segment is: Not disclosed in public notice (25). The buyers most represented are: NHS England (24), NHS England - North West (1). Activity from the latest reporting window provides a directional signal for whether supplier leadership is stabilising or rotating across buyers. If concentration remains high, teams should focus on precise account penetration and differentiation narratives; if concentration softens, challenger entry strategy can be broadened. This section helps procurement sales teams decide where to compete directly and where to build adjacent opportunities first.
What this means for your bid strategy
In NHS England contracts, supplier concentration patterns should guide where to challenge and where to partner. If a few suppliers dominate, plan displacement strategy around specific buyers and contract types. If concentration is lower, widen pursuit coverage and test new account entry points. The key is to convert supplier visibility into practical bid allocation decisions each cycle.
Data coverage note
Supplier disclosure coverage is currently 0% in this slice. Use buyer, value and date patterns as primary signals, and treat supplier analysis as directional where disclosure is limited.
See upcoming renewals and competitors
Move from reactive tender search to proactive pipeline qualification with earlier signals.